Kinnate Biopharma Inc. Common Stock is a biotechnology company focused on developing targeted therapies for genetically-driven cancers. Their innovative approach harnesses precision medicine to identify and target specific genetic mutations, aiming to improve patient outcomes and revolutionize cancer treatment.
Notification